Page 2 - Yield10 Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

-Prioritizes Activities to Advance Omega-3 Camelina Program in 2024 -Reports Completion of Contra Season Production of Omega-3 Camelina Seed in Chile -...

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) shares passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.46 and traded as high as $0.57. Yield10 Bioscience shares last traded at $0.35, with a volume of 128,405,482 shares changing hands. Wall […]

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Free Report) – Equities researchers at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Yield10 Bioscience in a report issued on Thursday, November 16th. HC Wainwright analyst A. Dayal now forecasts that the specialty chemicals company will post earnings of $0.05 per share for the year, down […]

Yield10 Bioscience, Inc. (NASDAQ:YTEN – Free Report) – HC Wainwright lowered their FY2027 earnings estimates for Yield10 Bioscience in a note issued to investors on Thursday, November 16th. HC Wainwright analyst A. Dayal now forecasts that the specialty chemicals company will post earnings per share of $0.05 for the year, down from their prior estimate […]

Yield10 Bioscience and BioMar Group have signed an agreement to form a long-term partnership to commercialize a Camelina crop containing enriched levels of EPA and DHA.